Showing results (31-40 of 109) with videos related to
Sort By:
Pageof 11
Drug and Alcohol Dependence|February 13, 2018
Similarities and changes between 15- and 24-year survival and retention rates of patients in a large medical-affiliated methadone maintenance treatment (MMT) centerEinat Peles, Shaul Schreiber, Anat Sason, et al.Drug and Alcohol Dependence|June 2, 2018
Pregabalin misuse in methadone maintenance treatment patients in Israel: Prevalence and risk factorsAnat Sason, Miriam Adelson, Shaul Schreiber, et al.Journal of Psychoactive Drugs|December 28, 2020
Pregabalin Misuse: Motives, Pattern, and Knowledge about Its Risks among Patients in Methadone Maintenance TreatmentEinat Peles, Anat Sason, Shaul Schreiber, et al.Drug and Alcohol Dependence|June 28, 2021
The prevalence of constipation and its relation to sweet taste preference among patients receiving methadone maintenance treatmentAnat Sason, Miriam Adelson, Shaul Schreiber, et al.Journal of Addiction Medicine|August 17, 2011
Low risk for hepatitis C seroconversion in methadone maintenance treatmentEinat Peles, Shaul Schreiber, Vera Rados, et al.Journal of Addiction Medicine|July 20, 2011
Earning "take-home" privileges and long-term outcome in a methadone maintenance treatment programEinat Peles, Shaul Schreiber, Anat Sason, et al.European Addiction Research|March 9, 2012
Long waiting period to enter methadone maintenance treatment: relation to patient characteristics and outcomeEinat Peles, Shaul Schreiber, Anat Sason, et al.Journal of Affective Disorders|October 24, 2006
Depression in methadone maintenance treatment patients: rate and risk factorsEinat Peles, Shaul Schreiber, Yosef Naumovsky, et al.Journal of Psychiatric Research|February 18, 2026
Characteristics of retention and survival of lifetime pathological gambling in methadone maintenance treatmentEinat Peles, Anat Sason, Shaul Schreiber, et al.Journal of Addiction Medicine|January 21, 2014
Are 2 weeks of "take-home" privileges beneficial for patients' long-term outcome in a methadone maintenance treatment program?Miriam Adelson, Shaul Schreiber, Anat Sason, et al.Pageof 11